BWH Precision Medicine Program harnesses the power of big data in healthcare to maintain and restore health. The goal is to create decision support tools to provide patients and clinicians with easy-to-interpret, actionable information to make precise diagnoses and select the most effective, tailored treatment courses for individual patients across a given population. PMP brings together researchers and clinicians from fields, including genomics, proteomics, metabolomics, imaging and phenotypic data to gain a complete picture of an individual patient’s health, disease, and potential response to therapies. Join iHub as we welcome Jeff Golden, MD, and Claudia Rizzini, PhD to the April Digital Research Forum as they share more about the BWH Precision Medicine Program.

Jeffrey A. Golden is the Ramzi S. Cotran Professor of Pathology at Harvard Medical School and the Chair of Pathology at the Brigham and Women’s Hospital. In addition to his local roles he is a past president of the American Association of Neuropathologists, an Associate Editor for the Journal of Neuropathology and Experimental Neurology. He has served on many international, national and local committees, has organized numerous national and international meetings. His work has been recognized with a number of awards including the Litchfield Lectureship at Oxford College, the Dorothy Russell Memorial Lectureship from the British Neuropathology Society, and three times by the Weil Award from the American Association of Neuropathologists. His current efforts are focused on leading the development and implementation of Computational Pathology and Precision Medicine at the Brigham and Women’s Hospital.

Claudia Rizzini is the Managing Director of the Precision Medicine Program at Brigham and Women’s Hospital in Boston. She started her career at Cambridge University Hospital in the UK where she set up and managed the Research and Development Department. In 2008 Dr. Rizzini joined Harvard University as Program Director of the Harvard Stem Cell Institute where she expanded the institute research portfolio and fostered a diverse, collaborative community of stem cell scientists.

Dr. Rizzini has a Ph.D. in Neuroscience and holds a master’s degree in International Healthcare Management, Economics and Policy.